Boxer Capital, LLC
- SEC CIK
- 0001465837
- Latest filing
- Feb 14, 2025
XENE holding history
Xenon Pharmaceuticals Inc. in every 13F filed by Boxer Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
XENE overviewAll 13F holders of XENEFull Q4 2024 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −600,000−100.0% | Sold out | Holders |
| Q3 2024 | 600,000 | $23.6M | 1.2% | 00.0% | Unchanged | Holders |
| Q2 2024 | 600,000 | $23.4M | 1.2% | 00.0% | Unchanged | Holders |
| Q1 2024 | 600,000 | $25.8M | 1.3% | 00.0% | Unchanged | Holders |
| Q4 2023 | 600,000 | $27.6M | 1.4% | 00.0% | Unchanged | Holders |
| Q3 2023 | 600,000 | $20.5M | 1.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 600,000 | $23.1M | 1.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 600,000 | $21.5M | 1.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 600,000 | $23.7M | 1.3% | 00.0% | Unchanged | Holders |
| Q3 2022 | 600,000 | $21.7M | 1.2% | 00.0% | Unchanged | Holders |
| Q2 2022 | 600,000 | $18.3M | 1.2% | 00.0% | Unchanged | Holders |
| Q1 2022 | 600,000 | $18.3M | 0.9% | 00.0% | Unchanged | Holders |
| Q4 2021 | 600,000 | $18.7M | 0.7% | −257,000−30.0% | Reduced | Holders |
| Q3 2021 | 857,000 | $13.1M | 0.5% | 00.0% | Unchanged | Holders |
| Q2 2021 | 857,000 | $16.0M | 0.6% | +857,000 | New | Holders |